Medical Devices North America

North America Deep Brain Stimulation Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $863.1 Mn Placeholder estimate
Estimate 2025 $928.7 Mn 55.8% of the global market
Projected 2034 $1.80 Bn 93.3% Adds $866.8 Mn over 9 forecast years
CAGR 2025–2034 7.6% Faster than 49% of 173 Medical Devices markets here
Key players 5
  • North America is 55.83% of the global market.
  • Among regions, the largest is North America (this report) at $928.7 Mn.
  • Fastest growing: Africa at 10.4% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$866.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Deep Brain Stimulation Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $863.1 Mn — —
2025 (base) $928.7 Mn +$65.6 Mn —
2026 (forecast) $999.2 Mn +$70.6 Mn +7.6%
2027 (forecast) $1.08 Bn +$75.9 Mn +15.8%
2028 (forecast) $1.16 Bn +$81.7 Mn +24.6%
2029 (forecast) $1.24 Bn +$87.9 Mn +34%
2030 (forecast) $1.34 Bn +$94.6 Mn +44.2%
2031 (forecast) $1.44 Bn +$101.8 Mn +55.2%
2032 (forecast) $1.55 Bn +$109.5 Mn +67%
2033 (forecast) $1.67 Bn +$117.9 Mn +79.7%
2034 (forecast) $1.80 Bn +$126.8 Mn +93.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Deep Brain Stimulation Market Analysis at a glance
Market size, 2025$928.7 Mn placeholder estimate
Forecast, 2034$1.80 Bn placeholder estimate
Growth (CAGR), 2025–20347.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika, SceneRay (see all)
Active clinical trials149 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Deep Brain Stimulation Market Analysis Executive Summary

Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.

Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).

Bar chart: North America Deep Brain Stimulation market size, 2024–2034, placeholder estimates. $863.1 Mn in 2024, $928.7 Mn in 2025 and $1.80 Bn in 2034, 7.6% CAGR.
North America Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Deep Brain Stimulation Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.

Competitive Landscape for Deep Brain Stimulation Market in North America

The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in North America

Deep Brain Stimulation in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 149 studies on Deep Brain Stimulation that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Deep Brain Stimulation right now, from free public sources.

Clinical trials

149 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. Boston Scientific Corporation 4 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Deep Brain Stimulation in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Deep Brain Stimulation market in North America?
Placeholder estimate: about $928.7 Mn in 2025, rising to about $1.80 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in North America growing?
Placeholder estimate: about 7.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
How many clinical trials on Deep Brain Stimulation are running in North America?
149 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on brain and nerves

See the topic